ITI-214, a potent and selective PDE1 inhibitor, inhibits tumor growth when combined with a checkpoint inhibitor in a mouse model of breast cancer

被引：0
|
作者：
Voisin, Maud [1 ]
Goding, Stephen [1 ]
Snyder, Gretchen L. [1 ]
Davis, Robert E. [1 ]
机构：
[1] Intra Cellular Therapies Inc, New York, NY USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2577
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effects of ITI-214, a potent and selective phosphodiesterase type 1 inhibitor, on tumor myeloid cellular composition, tumor volume and survival in mouse models of colorectal cancer when combined with an anti-PD-1 checkpoint inhibitor.
    Snyder, Gretchen L.
    John, Peter A.
    Pulanco, Marc V.
    Zang, Xingxing
    Fienberg, Allen A.
    Davis, Robert E.
    CANCER RESEARCH, 2021, 81 (13)
  • [2] ITI-214, a Potent and Selective PDE 1 Inhibitor: A New Approach to the Treatment of Neurodegenerative Diseases, Including Parkinson's Disease
    O'Brien, Jennifer J.
    Dutheil, Sophie
    Cruz, Stephanie
    Wennogle, Lawrence P.
    O'Gorman, Cedric
    Li, Peng
    Davis, Robert E.
    Snyder, Gretchen L.
    Hendrick, Joseph P.
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S405 - S406
  • [3] ITI-1020, a novel PDE type 1 inhibitor, reduces tumor growth in triple negative breast cancer (TNBC) mouse models
    Voisin, Maud
    Kogan, Aksinija A.
    Goding, Stephen
    Snyder, Gretchen L.
    Davis, Robert E.
    CANCER RESEARCH, 2023, 83 (07)
  • [4] Checkpoint inhibitor therapy in combination with the implantation of agarose encapsulated cancer cells inhibits tumor growth in a mouse model of osteosarcoma
    Dumpala, Pradeep R.
    Martis, Prithy C.
    Bemrose, Melissa A.
    Dudley, Atira
    Smith, Barry H.
    Gazda, Lawrence S.
    CANCER RESEARCH, 2018, 78 (13)
  • [5] A novel PDE10 inhibitor suppresses tumor growth in an orthotopic mouse model of lung cancer
    Ramirez-Alcantara, Veronica
    Schuler, Michele A.
    Zhu, Bing
    Li, Nan
    Gurpinar, Evrim
    Canzoneri, Joshua
    Keeton, Adam
    Gary, Bernard
    Russo, Suzanne
    Coward, Lori
    Gorman, Gregory S.
    Grizzle, William
    Chen, Xi
    Piazza, Gary A.
    CANCER RESEARCH, 2014, 74 (19)
  • [6] BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo
    Steegmaier, Martin
    Hoffmann, Matthias
    Baum, Anke
    Lenart, Peter
    Petronczki, Mark
    Krssak, Martin
    Guertler, Ulrich
    Garin-Chesa, Pilar
    Lieb, Simone
    Quant, Jens
    Grauert, Matthias
    Adolf, Guenther R.
    Kraut, Norbert
    Peters, Jan-Michael
    Rettig, Wolfgang J.
    CURRENT BIOLOGY, 2007, 17 (04) : 316 - 322
  • [7] Sk-216, An Inhibitor Of Plasminogen Activator Inhibitor-1, Inhibits Tumor Growth In A Mouse Model Of Pleural Mesothelioma
    Takayama, Y.
    Hattori, N.
    Hamada, H.
    Masuda, T.
    Akita, S.
    Ishikawa, N.
    Fujitaka, K.
    Haruta, Y.
    Murai, H.
    Kohno, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [8] IMMUNE CHECKPOINT INHIBITOR COMBINED WITH THE GROWTH INHIBITOR LYCORINE SYNERGISTICALLY FUNCTION TO MEDIATE ANTI-TUMOR EFFECTS IN A MOUSE MODEL OF RENAL CELL CARCINOMA
    Li, Xiezhao
    Xu, Naijin
    Xu, Aibai
    Watanabe, Masami
    Huang, Peng
    Nasu, Yasutomo
    Liu, Chunxiao
    JOURNAL OF UROLOGY, 2017, 197 (04): : E963 - E963
  • [9] Xanthatin, a novel potent inhibitor of VEGFR2 signaling, inhibits angiogenesis and tumor growth in breast cancer cells
    Yu, Yao
    Yu, Jing
    Pei, Chong Gang
    Li, Yun Yan
    Tu, Ping
    Gao, Gui Ping
    Shao, Yi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (09): : 10355 - 10364
  • [10] The RANKL inhibitor osteoprotegerin (OPG) inhibits tumor growth, prevents tumor-induced osteolysis, and significantly improves survival in a mouse model of breast cancer bone metastasis
    Canon, J.
    Roudier, M.
    Bryant, R.
    Radinsky, R.
    Dougall, W.
    EJC SUPPLEMENTS, 2006, 4 (12): : 166 - 167
12345